Oncogenic Role of EEPD1 via Protein Kinase B Phosphorylation in Colorectal Cancer.
1/5 보강
[INTRODUCTION] Endonuclease/exonuclease/phosphatase family domain-containing 1 (EEPD1) is involved in deoxyribonucleic acid (DNA) repair and promotes the repair of oxidative-stressed replication forks
- p-value P = 0.0001
- p-value P = 0.046
APA
Ma R, Shimura T, et al. (2025). Oncogenic Role of EEPD1 via Protein Kinase B Phosphorylation in Colorectal Cancer.. The Journal of surgical research, 315, 677-687. https://doi.org/10.1016/j.jss.2025.09.067
MLA
Ma R, et al.. "Oncogenic Role of EEPD1 via Protein Kinase B Phosphorylation in Colorectal Cancer.." The Journal of surgical research, vol. 315, 2025, pp. 677-687.
PMID
41130103 ↗
Abstract 한글 요약
[INTRODUCTION] Endonuclease/exonuclease/phosphatase family domain-containing 1 (EEPD1) is involved in deoxyribonucleic acid (DNA) repair and promotes the repair of oxidative-stressed replication forks. This study explored the oncological importance of EEPD1 in colorectal cancer (CRC).
[METHODS] We first evaluated the levels of EEPD1 mRNA by reverse transcription-quantitative polymerase chain reaction (PCR) and of EEPD1 protein by immunohistochemistry in samples from 289 CRC patients. We then investigated the cancer-promoting function of EEPD1 by performing a series of in vitro assays in CRC cells (SW620 and WiDr) to assess cell proliferation, migration, apoptosis, and signal transduction.
[RESULTS] We revealed that the mRNA and protein levels of EEPD1 were remarkably higher in tumor tissues than in adjacent normal mucosa. Furthermore, patients with high levels of EEPD1 showed significantly poorer overall survival (P = 0.0001) and recurrence-free survival (P = 0.046). Moreover, siRNA knockdown of EEPD1 significantly inhibited cell proliferation (P < 0.05) and migration activity (P < 0.05), enhanced apoptotic activity (P < 0.05), and reduced phosphorylation of protein kinase B (AKT) in SW620 and WiDr CRC cells (P < 0.05).
[CONCLUSIONS] EEPD1 is a promising prognostic and recurrence-predictive biomarker in CRC patients and is a potential therapeutic target in CRC.
[METHODS] We first evaluated the levels of EEPD1 mRNA by reverse transcription-quantitative polymerase chain reaction (PCR) and of EEPD1 protein by immunohistochemistry in samples from 289 CRC patients. We then investigated the cancer-promoting function of EEPD1 by performing a series of in vitro assays in CRC cells (SW620 and WiDr) to assess cell proliferation, migration, apoptosis, and signal transduction.
[RESULTS] We revealed that the mRNA and protein levels of EEPD1 were remarkably higher in tumor tissues than in adjacent normal mucosa. Furthermore, patients with high levels of EEPD1 showed significantly poorer overall survival (P = 0.0001) and recurrence-free survival (P = 0.046). Moreover, siRNA knockdown of EEPD1 significantly inhibited cell proliferation (P < 0.05) and migration activity (P < 0.05), enhanced apoptotic activity (P < 0.05), and reduced phosphorylation of protein kinase B (AKT) in SW620 and WiDr CRC cells (P < 0.05).
[CONCLUSIONS] EEPD1 is a promising prognostic and recurrence-predictive biomarker in CRC patients and is a potential therapeutic target in CRC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Therapeutic role of caveolin family in stem cell fate and development for management of chronic degenerative diseases: A scientometric study to an in-depth review.
- CLK1 is a potential tumor suppressor for NSCLC by regulating cell proliferation and immune infiltration.
- Identification of mitochondrial oxidative stress-related genes for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma.
- Survival benefit of allogeneic HSCT in CMML patients during the molecular stratification era.
- Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.